CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
-9.83%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$80.4M
AUM Growth
+$80.4M
(-34%)
Cap. Flow
-$30.8M
Cap. Flow
% of AUM
-38.28%
Top 10 Holdings %
Top 10 Hldgs %
79.62%
Holding
53
New
1
Increased
2
Reduced
24
Closed
16
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$4.05M |
| 2 |
Arcellx
ACLX
|
$1.25M |
| 3 |
ELEV
Elevation Oncology
ELEV
|
$32.7K |
Top Sells
Sector Composition
| 1 | Healthcare | 57.31% |
| 2 | Financials | 10.5% |
| 3 | Communication Services | 5.09% |
| 4 | Technology | 4.29% |
| 5 | Consumer Discretionary | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
KALA BIO
KALA
$78.8M
| – | – |
-13,155
| Closed | -$16K |
|
52
MoonLake Immunotherapeutics
MLTX
$3.54B
| – | – |
-16,009
| Closed | -$158K |
|
|
AAC.U
53
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
| – | – |
-139,680
| Closed | -$1.39M |
|